Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $1.86 Million - $2.68 Million
-15,389 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $8.36 Million - $9.39 Million
-49,854 Reduced 76.41%
15,389 $2.67 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $67,017 - $79,173
-418 Reduced 0.64%
65,243 $11.7 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $10.6 Million - $11.7 Million
65,661 New
65,661 $10.6 Million
Q4 2017

Feb 13, 2018

SELL
$147.99 - $163.95 $2.4 Million - $2.66 Million
-16,231 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $2.43 Million - $2.61 Million
16,231
16,231 $2.45 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.